Todas las investigaciones
ReclutamientoOBSERVACIONAL

Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma

This research is investigating a new way to monitor glaucoma, an eye condition that can cause irreversible vision loss. Glaucoma damages the optic nerve and progressively reduces vision. The study focuses on advanced glaucoma patients and aims to understand how their condition changes over three years using a special eye scan called Optical Coherence Tomography Angiography (OCTa). This scan looks at tiny blood vessels in the eye. Researchers will compare OCTa results with traditional eye tests, like visual field tests and another type of OCT scan, to see which methods are best at tracking the progression of glaucoma. The goal is to find better ways to detect changes early and manage this challenging eye disease.

De un vistazo

Estado
Reclutamiento
Patrocinador
Nantes University Hospital
Objetivo de inscripción
50
Inicio
27 de abril de 2024
Estimación de finalización
01 Sep 2027

¿De qué trata este estudio?

This study is about understanding how glaucoma affects people over time, especially those with advanced forms of the condition. Glaucoma is a serious eye disease where the nerve that connects your eye to your brain (called the optic nerve) gets damaged. This damage can lead to a gradual loss of vision, starting from the edges of your sight and sometimes affecting your central vision too. It's a common cause of blindness, and once vision is lost, it usually can't be restored.

Doctors have different ways to check for glaucoma and see if it's getting worse. One common test is a 'visual field test,' which checks for blind spots in your vision. Another is a regular OCT scan, which measures the thickness of your optic nerve. This study is excited about a newer type of scan called Optical Coherence Tomography Angiography (OCTa). This special scan creates detailed pictures of the tiny blood vessels around your optic nerve.

The main aim of this research is to compare how well these three types of tests – the visual field test, the regular OCT, and the new OCTa scan – show changes in glaucoma over a three-year period. By doing this, researchers hope to discover if the OCTa scan can provide valuable new information that helps doctors track glaucoma more effectively and potentially detect progression earlier. This could lead to better management and care for people living with glaucoma.

Puntos clave

  • The study aims to understand glaucoma progression using new imaging.
  • It focuses on advanced glaucoma patients over a three-year period.
  • Compares a new OCT scan (OCTa) with standard eye tests.
  • Hopes to find better ways to track glaucoma changes.
  • No new treatments are given; it's an observational study.
  • Participation involves regular eye scans and vision tests.

¿Quién puede ser elegible?

To join this study, you need to be a man or woman aged 18 or older. You must also be a patient who is already being treated for glaucoma at the ophthalmology department of Nantes University Hospital in France. An important requirement is that your glaucoma must be considered 'advanced,' which means a specific measurement of your visual field (called 'mean visual field deficit' or MD) needs to be greater than 10dB.

There are also some reasons why you might not be able to join. For example, if you have other serious eye conditions that affect your blood vessels or cause vision loss, like certain types of diabetic eye disease or macular degeneration, or if you've had certain eye surgeries like retinal panphotocoagulation, you wouldn't be eligible. Conditions that cause vision problems not related to glaucoma, such as certain brain conditions (like a stroke that affects vision), would also prevent you from participating.

Other reasons for not being able to take part include issues that would make eye scans or tests difficult or unreliable. This means things like severe cataracts or active eye inflammation. Furthermore, pregnant or breastfeeding women cannot participate, nor can adults under legal guardianship. Finally, if your visual field tests are often unreliable, or if your eye scans (OCT or OCTa) are of poor quality and hard to interpret, you wouldn't be able to join the study.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Tienes 18 años o más?
  2. Are you a patient with glaucoma at Nantes University Hospital?
  3. Has your doctor told you your glaucoma is considered 'advanced' (MD > 10dB)?
  4. Do you *not* have other serious eye conditions that could affect your vision tests (like severe diabetic eye disease or macular degeneration)?
  5. Are you *not* pregnant or breastfeeding?
  6. Are your regular eye tests and scans usually reliable and clear?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

This study involves following your eye condition over a three-year period. You'll continue to visit the ophthalmology department at Nantes University Hospital for your appointments. During these visits, the researchers will perform three main types of tests:

1. **Visual Field Tests:** These tests check for any blind spots or areas of reduced vision in your peripheral and central sight. 2. **Regular OCT Scans:** These are detailed scans of your optic nerve that measure its thickness. 3. **OCTa Scans:** This is the newer scan that looks at the blood flow in the tiny vessels around your optic nerve.

You won't be given any new medications specifically for this study. Your participation will involve having these tests done regularly over the three years to track how your glaucoma progresses. The total duration of your active involvement in the study will be three years, with follow-up scans and tests during that time.

Riesgos y beneficios potenciales

Participating in this study might not directly benefit you, but the information gained could help doctors better understand and treat glaucoma in the future. The tests involved, such as visual field tests and OCT scans, are standard, non-invasive procedures that are generally safe and don't carry significant risks beyond typical eye examinations. You have the right to withdraw from the study at any time without giving a reason, and this will not affect your usual medical care.

Ubicaciones (2)

  • CHU Nantes
    Código postal verificado
    Nantes, France· Reclutamiento
  • Jean-Baptiste Ducloyer
    Código postal verificado
    Nantes, France· Aún no reclutando

Preguntas comunes

What is advanced glaucoma?

Advanced glaucoma means your condition has progressed to a certain level, usually indicating more significant damage to your optic nerve and more noticeable changes in your vision.

What is an OCT scan?

OCT (Optical Coherence Tomography) is a special scan that takes detailed pictures of the inside of your eye, like a tiny ultrasound using light. It helps doctors see the nerve layers and blood vessels.

¿Recibiré un nuevo tratamiento en este estudio?

No, this study is about monitoring your glaucoma with existing and new scanning techniques, not about providing new treatments or medications.

¿Cuánto tiempo estaré en el estudio?

Your participation in the study will last for three years, during which you'll have regular eye tests and scans.

¿Puedo abandonar el estudio si cambio de opinión?

Yes, you can choose to leave the study at any point, and your decision will not affect your medical care.

Cómo obtener más información

Jean-Baptiste Ducloyer, M.D

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "Study of OCT Peripapillary Angiography in Patients With Adva…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.